Hankyel Park

Array ( [id] => 1400551 [patent_doc_number] => 06534310 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Suppression of proteolytic activity by dysfunctional protease formation' [patent_app_type] => B1 [patent_app_number] => 09/587577 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 8884 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534310.pdf [firstpage_image] =>[orig_patent_app_number] => 09587577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1574295 [patent_doc_number] => 06468737 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders' [patent_app_type] => B1 [patent_app_number] => 09/585651 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 22874 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468737.pdf [firstpage_image] =>[orig_patent_app_number] => 09585651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1564755 [patent_doc_number] => 06338962 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Use of a non-mammalian DNA virus to express an exogenous gene in a mammalian cell' [patent_app_type] => B1 [patent_app_number] => 09/579744 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 25 [patent_no_of_words] => 21094 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/338/06338962.pdf [firstpage_image] =>[orig_patent_app_number] => 09579744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1484802 [patent_doc_number] => 06365372 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'SNF2 related CBP activator protein (SRCAP)' [patent_app_type] => B1 [patent_app_number] => 09/579181 [patent_app_country] => US [patent_app_date] => 2000-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 31464 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365372.pdf [firstpage_image] =>[orig_patent_app_number] => 09579181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1476766 [patent_doc_number] => 06451323 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Recombinant newcastle disease virus RNA expression systems and vaccines' [patent_app_type] => B1 [patent_app_number] => 09/576567 [patent_app_country] => US [patent_app_date] => 2000-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12567 [patent_no_of_claims] => 126 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451323.pdf [firstpage_image] =>[orig_patent_app_number] => 09576567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625611 [patent_doc_number] => 06723558 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-20 [patent_title] => 'Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses' [patent_app_type] => B1 [patent_app_number] => 09/568105 [patent_app_country] => US [patent_app_date] => 2000-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21451 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723558.pdf [firstpage_image] =>[orig_patent_app_number] => 09568105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517002 [patent_doc_number] => 06500641 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Compositions and methods for identifying antigens which elicit an immune response' [patent_app_type] => B1 [patent_app_number] => 09/566420 [patent_app_country] => US [patent_app_date] => 2000-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 54 [patent_no_of_words] => 30860 [patent_no_of_claims] => 119 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500641.pdf [firstpage_image] =>[orig_patent_app_number] => 09566420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4367145 [patent_doc_number] => 06287817 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Fusion proteins for protein delivery' [patent_app_type] => 1 [patent_app_number] => 9/559393 [patent_app_country] => US [patent_app_date] => 2000-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 11358 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287817.pdf [firstpage_image] =>[orig_patent_app_number] => 559393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417325 [patent_doc_number] => 06518239 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Dry powder compositions having improved dispersivity' [patent_app_type] => B1 [patent_app_number] => 09/548759 [patent_app_country] => US [patent_app_date] => 2000-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14713 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518239.pdf [firstpage_image] =>[orig_patent_app_number] => 09548759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1400035 [patent_doc_number] => 06534285 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use' [patent_app_type] => B1 [patent_app_number] => 09/547692 [patent_app_country] => US [patent_app_date] => 2000-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 26 [patent_no_of_words] => 21493 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534285.pdf [firstpage_image] =>[orig_patent_app_number] => 09547692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1484977 [patent_doc_number] => 06365404 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Hematopoietic cell method for treatment of HIV infection' [patent_app_type] => B1 [patent_app_number] => 09/545365 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1721 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365404.pdf [firstpage_image] =>[orig_patent_app_number] => 09545365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4393901 [patent_doc_number] => 06297049 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Methods and compositions for ameliorating the symptoms of sepsis' [patent_app_type] => 1 [patent_app_number] => 9/542118 [patent_app_country] => US [patent_app_date] => 2000-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12052 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297049.pdf [firstpage_image] =>[orig_patent_app_number] => 542118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1273500 [patent_doc_number] => 06649409 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => 'Method for producing a nucleotide sequence construct with optimized codons for an HIV genetic vaccine based on a primary, early HIV isolate and synthetic envelope BX08 constructs' [patent_app_type] => B1 [patent_app_number] => 09/536977 [patent_app_country] => US [patent_app_date] => 2000-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 36 [patent_no_of_words] => 44819 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649409.pdf [firstpage_image] =>[orig_patent_app_number] => 09536977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560858 [patent_doc_number] => 06361974 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Exonuclease-mediated nucleic acid reassembly in directed evolution' [patent_app_type] => B1 [patent_app_number] => 09/535754 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 68199 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/361/06361974.pdf [firstpage_image] =>[orig_patent_app_number] => 09535754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1536703 [patent_doc_number] => 06337386 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Toxin Assay' [patent_app_type] => B1 [patent_app_number] => 09/534572 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9682 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337386.pdf [firstpage_image] =>[orig_patent_app_number] => 09534572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414525 [patent_doc_number] => 06511830 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Killer T cell receptor recognizing human immunodeficiency virus' [patent_app_type] => B1 [patent_app_number] => 09/509347 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16118 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511830.pdf [firstpage_image] =>[orig_patent_app_number] => 09509347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349447 [patent_doc_number] => 06291236 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Human cytomegalovirus DNA sequences' [patent_app_type] => 1 [patent_app_number] => 9/527657 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 26569 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291236.pdf [firstpage_image] =>[orig_patent_app_number] => 527657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1489980 [patent_doc_number] => 06416997 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery' [patent_app_type] => B1 [patent_app_number] => 09/525392 [patent_app_country] => US [patent_app_date] => 2000-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 35 [patent_no_of_words] => 11460 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/416/06416997.pdf [firstpage_image] =>[orig_patent_app_number] => 09525392 [rel_patent_id] =>[rel_patent_doc_number] =>)